Spironolactone
Product Images NDC 10544-523

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 10544-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 30ct (Label Spironolactone Tabs 25mg Bpi(10544 523 30) Amneal(65162 511 11) Rev2)

Spironolactone Tablets, USP 25mg label showing a 30-tablet count bottle. The label includes storage instructions for room temperature and light-resistant container. Labeler is Blenheim Pharmacal, Inc. The NDC is 10544-523-30. The label also features a barcode and a section with multiple small repeating labels of the same product details.*

FDA Label Image

Structure (Spironolactone Tablets Usp 1)

Chemical structure of spironolactone depicted as a molecular diagram showing its arrangement of atoms and bonds in a steroid-like framework with key functional groups including a lactone ring and a thioacetate moiety.*

FDA Label Image

Structure (Spironolactone Tablets Usp 2)

A survival probability curve comparing Spironolactone (n=822) with Placebo (n=841) over a period of 48 months. The graph shows two lines indicating higher probability over time for Spironolactone compared to Placebo, with a log-rank p-value of less than 0.001.*

FDA Label Image

Graph3 (Spironolactone Tablets Usp 3)

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for Spironolactone across different subgroups including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot compares Spironolactone effects to placebo, indicating regions where Spironolactone is better or placebo is better.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.